237 related articles for article (PubMed ID: 17592298)
1. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.
Eilber FC; Brennan MF; Eilber FR; Eckardt JJ; Grobmyer SR; Riedel E; Forscher C; Maki RG; Singer S
Ann Surg; 2007 Jul; 246(1):105-13. PubMed ID: 17592298
[TBL] [Abstract][Full Text] [Related]
2. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.
Eilber FC; Eilber FR; Eckardt J; Rosen G; Riedel E; Maki RG; Brennan MF; Singer S
Ann Surg; 2004 Oct; 240(4):686-95; discussion 695-7. PubMed ID: 15383796
[TBL] [Abstract][Full Text] [Related]
3. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients.
Canter RJ; Qin LX; Maki RG; Brennan MF; Ladanyi M; Singer S
Clin Cancer Res; 2008 Dec; 14(24):8191-7. PubMed ID: 19088035
[TBL] [Abstract][Full Text] [Related]
4. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS
Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients.
Chen Y; Yang Y; Wang C; Shi Y
J Surg Oncol; 2012 Aug; 106(2):162-8. PubMed ID: 22297839
[TBL] [Abstract][Full Text] [Related]
6. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.
Lewis JJ; Antonescu CR; Leung DH; Blumberg D; Healey JH; Woodruff JM; Brennan MF
J Clin Oncol; 2000 May; 18(10):2087-94. PubMed ID: 10811674
[TBL] [Abstract][Full Text] [Related]
7. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.
Italiano A; Penel N; Robin YM; Bui B; Le Cesne A; Piperno-Neumann S; Tubiana-Hulin M; Bompas E; Chevreau C; Isambert N; Leyvraz S; du Chatelard PP; Thyss A; Coindre JM; Blay JY
Ann Oncol; 2009 Mar; 20(3):425-30. PubMed ID: 19088169
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution.
Pisters PW; Patel SR; Varma DG; Cheng SC; Chen NP; Nguyen HT; Feig BW; Pollack A; Pollock RE; Benjamin RS
J Clin Oncol; 1997 Dec; 15(12):3481-7. PubMed ID: 9396401
[TBL] [Abstract][Full Text] [Related]
9. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of prognostic factors for synovial sarcoma].
Du ZY; Guo W; Yang RL; Yan TQ; Li DS
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):991-4. PubMed ID: 22333419
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.
Yaser S; Salah S; Al-Shatti M; Abu-Sheikha A; Shehadeh A; Sultan I; Salem A; Sughayer M; Al-Loh S; Al-Mousa A
Med Oncol; 2014 Jun; 31(6):958. PubMed ID: 24770952
[TBL] [Abstract][Full Text] [Related]
12. Systemic Treatment for Adults with Synovial Sarcoma.
Desar IME; Fleuren EDG; van der Graaf WTA
Curr Treat Options Oncol; 2018 Mar; 19(2):13. PubMed ID: 29516254
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens.
Ray-Coquard I; Le Cesne A; Whelan JS; Schoffski P; Bui BN; Verweij J; Marreaud S; van Glabbeke M; Hogendoorn P; Blay JY
Oncologist; 2008 Apr; 13(4):467-73. PubMed ID: 18448563
[TBL] [Abstract][Full Text] [Related]
15. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal Synovial Sarcoma: A Systematic Review of the Last 40 Years of Reported Cases.
Shein G; Sandhu G; Potter A; Loo C; Jacobson I; Anazodo A
Ear Nose Throat J; 2021 Feb; 100(2):NP93-NP104. PubMed ID: 31309846
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999.
Bacci G; Ferrari S; Mercuri M; Longhi A; Fabbri N; Galletti S; Forni C; Balladelli A; Serra M; Picci P
Acta Orthop; 2007 Jun; 78(3):377-84. PubMed ID: 17611853
[TBL] [Abstract][Full Text] [Related]
18. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.
Salah S; Yaser S; Salem A; Al Mousa A; Abu Sheikha A; Sultan I
Med Oncol; 2013; 30(3):639. PubMed ID: 23780657
[TBL] [Abstract][Full Text] [Related]
20. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide.
Rosen G; Forscher C; Lowenbraun S; Eilber F; Eckardt J; Holmes C; Fu YS
Cancer; 1994 May; 73(10):2506-11. PubMed ID: 8174046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]